San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Half-Dozen Life Science Firms Report Earnings

Six San Diego County life science firms reported quarterly earnings and corporate updates.

Neuropore Therapies Inc. Launches Phase 1 Clinical Trial For Parkinson's Treatment

Neuropore Therapies Inc., a biopharmaceutical company in San Diego, has launched Phase 1 clinical trials for its drug candidate NPT200-11, a potential treatment for Parkinson’s disease.

Imprimis Signs License Agreement With Advanced Dosage

Imprimis Pharmaceuticals Inc., a company developing drug combo formulations, announced Wednesday that it has entered into a license agreement with Advanced Dosage Forms Inc.

PatientSafe Solutions Appoints CFO

PatientSafe Solutions, which provides point-of-care mobile solutions for health care, has named Balaji Sekar its chief financial officer.

Scripps Health Launches Informational App

Scripps Health has launched a new app that provides patients and visitors with access to information about physicians and Scripps hospitals and clinics via smartphones and tablets.

DexCom, Google Partner on Diabetes-Related Products

Medical device maker DexCom is partnering with Google Life Sciences to develop a new generation of smaller, less expensive continuous glucose monitors (CGM) for people with diabetes.

Drugmaker Zogenix Reports Q2 Revenue of $7.4 Million

San Diego drugmaker Zogenix reported revenue of $7.4 million in the second quarter of 2015, up from $6.7 million in the same quarter last year.

MabVax Posts Net Loss of $6.4 Million for Second Quarter

Cancer vaccine-maker MabVax Therapeutics Holdings Inc. reported a net loss of $6.4 million in the second quarter of this year, up from $2.4 million in the same period last year.

Sorrento Therapeutics Subsidiary Acquires Immunotherapy Programs, Technology

A wholly owned subsidiary of Sorrento Therapeutics Inc. has acquired multiple preclinical and clinical stage chimeric antigen receptor immunotherapy programs as well as underlying CAR-T technology.

Conatus Says R&D Expenses Contributed to Q2 Net Loss of $6.1 Million

Conatus Pharmaceuticals Inc., a biotech focused on the development and commercialization of liver disease drugs, announced financial results Friday for the second quarter.

Poseida Therapeutics Appoints Two to Board of Directors

Poseida Therapeutics Inc., a therapeutics spin out of Transposagen Biopharmaceuticals Inc., announced the appointment of Dr. Lars Ekman and Dr. Nishan de Silva to the company's Board of Directors.

Donation Aims to Help More Students Access STEM Studies

A donation from medical device maker ResMed Inc. is being used to launch a program in San Diego to prepare low-income students for the left-brain jobs that dominate the local economy.

MabVax, The Rockefeller University Announce Collaboration

San Diego-based MabVax Therapeutics Holdings Inc., an oncology company working on cancer vaccines, has entered into a research collaboration with The Rockefeller University.

USC, UCSD Clash Brings Flaws Forward

BIOTECH: Its Alzheimer’s Program Will Be Revamped

Leaders at the University of California, San Diego’s medical school are brainstorming ways to safeguard the university’s reputation in response to an ongoing legal dispute that gets uglier by the day.

AMN Healthcare Stock Gets Boost After Strong Earnings Report

AMN Healthcare Services stock hit a new 52-week high during mid-day trading on Wednesday following a stronger than expected earnings report.